By using B16 melanoma cells producing OVA as a surrogate TAA and employing detection methods as those described above for α-gal liposomes containing OVA [46], it was possible to demonstrate effective in vivo uptake of the tumor cells by APC in lesions injected with α-gal glycolipids [57]. The gene discussed is APC; the disease is neoplasm.